David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 2,500 shares at $20.01 ($50K) on 2016-09-16, disclosed to the SEC on 2016-09-20.
Scheduled sale ($50k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 1,700 | $34K | 68.0% |
| 2 | $20.02 | 700 | $14K | 28.0% |
| 3 | $20.00 | 100 | $2K | 4.0% |
| Total | $20.01 avg | 2,500 | $50K | 100% |
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |